{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:21:19Z","timestamp":1778872879501,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T00:00:00Z","timestamp":1479427200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s11060-016-2321-8","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T23:31:52Z","timestamp":1479425512000},"page":"555-563","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Longitudinal experience with WHO Grade III (anaplastic) meningiomas at a single institution"],"prefix":"10.1007","volume":"131","author":[{"given":"Suresh K.","family":"Balasubramanian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayur","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danilo","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidhya","family":"Karivedu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glen H.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gene H.","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Prayson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Elson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin S.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel T.","family":"Chao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,18]]},"reference":[{"key":"2321_CR1","first-page":"iv1","volume":"17","author":"QT Ostrom","year":"2015","unstructured":"Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2015) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008\u20132012. Neurooncol 17:iv1\u2013iv62","journal-title":"Neurooncol"},{"key":"2321_CR2","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1002\/cncr.29379","volume":"121","author":"TA Dolecek","year":"2015","unstructured":"Dolecek TA, Dressler EV, Thakkar JP, Liu M, Al-Qaisi A, Villano JL (2015) Epidemiology of meningiomas post-Public Law 107\u2013206: the Benign Brain Tumor Cancer Registries Amendment Act. Cancer 121:2400\u20132410. doi: 10.1002\/cncr.29379","journal-title":"Cancer"},{"key":"2321_CR3","unstructured":"SEER Surveillance, Epidemiology, and End Results (SEER) Program ( http:\/\/www.seer.cancer.gov ) research data (1973\u20132012), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2015, based on the November 2014 submission"},{"key":"2321_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11060-013-1183-6","volume":"114","author":"S Ambekar","year":"2013","unstructured":"Ambekar S, Sharma M, Madhugiri VS, Nanda A (2013) Trends in intracranial meningioma surgery and outcome: a nationwide inpatient sample database analysis from 2001 to 2010. J Neurooncol 114:299\u2013307. doi: 10.1007\/s11060-013-1183-6","journal-title":"J Neurooncol"},{"key":"2321_CR5","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol (Berl) 131:803\u2013820. doi: 10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol (Berl)"},{"key":"2321_CR6","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1227\/01.NEU.0000188281.91351.B9","volume":"57","author":"EB Claus","year":"2005","unstructured":"Claus EB, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M, Black PM (2005) Epidemiology of intracranial meningioma. Neurosurgery 57:1088\u20131095","journal-title":"Neurosurgery"},{"key":"2321_CR7","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.ijrobp.2011.08.010","volume":"83","author":"S Adeberg","year":"2012","unstructured":"Adeberg S, Hartmann C, Welzel T, Rieken S, Habermehl D, von Deimling A, Debus J, Combs SE (2012) Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas\u2013clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy. Int J Radiat Oncol Biol Phys 83:859\u2013864. doi: 10.1016\/j.ijrobp.2011.08.010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2321_CR8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11060-009-9934-0","volume":"95","author":"A Durand","year":"2009","unstructured":"Durand A, Labrousse F, Jouvet A, Bauchet L, Kalamarid\u00e8s M, Menei P, Deruty R, Moreau JJ, F\u00e8vre-Montange M, Guyotat J (2009) WHO Grade II and III meningiomas: a study of prognostic factors. J Neurooncol 95:367\u2013375","journal-title":"J Neurooncol"},{"key":"2321_CR9","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s00701-011-1073-7","volume":"153","author":"M El-Khatib","year":"2011","unstructured":"El-Khatib M, El Majdoub F, Hoevels M, Kocher M, Muller RP, Steiger HJ, Sturm V, Maarouf M (2011) Stereotactic LINAC radiosurgery for incompletely resected or recurrent atypical and anaplastic meningiomas. Acta Neurochir (Wien) 153:1761\u20131767. doi: 10.1007\/s00701-011-1073-7","journal-title":"Acta Neurochir (Wien)"},{"key":"2321_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1748-717x-9-38","volume":"9","author":"DJ Ferraro","year":"2014","unstructured":"Ferraro DJ, Funk RK, Blackett JW, Ju MR, DeWees TA, Chicoine MR, Dowling JL, Rich KM, Drzymala RE, Zoberi I, Simpson JR, Jaboin JJ (2014) A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas. Rad Oncol (London, England) 9:38. doi: 10.1186\/1748-717x-9-38","journal-title":"Rad Oncol (London, England)"},{"key":"2321_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3171\/2014.10.jns14502","volume":"123","author":"J Moliterno","year":"2015","unstructured":"Moliterno J, Cope WP, Vartanian ED, Reiner AS, Kellen R, Ogilvie SQ, Huse JT, Gutin PH (2015) Survival in patients treated for anaplastic meningioma. J Neurosurg 123:23\u201330. doi: 10.3171\/2014.10.jns14502","journal-title":"J Neurosurg"},{"key":"2321_CR12","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1002\/cncr.26362","volume":"118","author":"BE Pollock","year":"2012","unstructured":"Pollock BE, Stafford SL, Link MJ, Garces YI, Foote RL (2012) Stereotactic radiosurgery of World Health Organization Grade II and III intracranial meningiomas: treatment results on the basis of a 22-year experience. Cancer 118:1048\u20131054. doi: 10.1002\/cncr.26362","journal-title":"Cancer"},{"key":"2321_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ijrobp.2008.08.018","volume":"74","author":"LA Rosenberg","year":"2009","unstructured":"Rosenberg LA, Prayson RA, Lee J, Reddy C, Chao ST, Barnett GH, Vogelbaum MA, Suh JH (2009) Long-term experience with World Health Organization Grade III (malignant) meningiomas at a single institution. Int J Radiat Oncol Biol Phys 74:427\u2013432. doi: 10.1016\/j.ijrobp.2008.08.018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2321_CR14","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3171\/2010.1.jns091114","volume":"113","author":"ME Sughrue","year":"2010","unstructured":"Sughrue ME, Sanai N, Shangari G, Parsa AT, Berger MS, McDermott MW (2010) Outcome and survival following primary and repeat surgery for World Health Organization Grade III meningiomas. J Neurosurg 113:202\u2013209. doi: 10.3171\/2010.1.jns091114","journal-title":"J Neurosurg"},{"key":"2321_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10143-014-0558-2","volume":"38","author":"P Zhao","year":"2015","unstructured":"Zhao P, Hu M, Zhao M, Ren X, Jiang Z (2015) Prognostic factors for patients with atypical or malignant meningiomas treated at a single center. Neurosurgical review 38: 101\u2013107. doi: 10.1007\/s10143-014-0558-2 (discussion 107)","journal-title":"Neurosurgical review"},{"key":"2321_CR16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11060-014-1507-1","volume":"119","author":"Y Choi","year":"2014","unstructured":"Choi Y, Lim DH, Jo K, Nam D-H, Seol HJ, Lee J-I (2014) Efficacy of postoperative radiotherapy for high grade meningiomas. J Neurooncol 119:405\u2013412","journal-title":"J Neurooncol"},{"key":"2321_CR17","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3171\/2010.3.JNS091971","volume":"113","author":"ME Sughrue","year":"2010","unstructured":"Sughrue ME, Kane AJ, Shangari G, Rutkowski MJ, McDermott MW, Berger MS, Parsa AT (2010) The relevance of Simpson Grade I and II resection in modern neurosurgical treatment of World Health Organization Grade I meningiomas: clinical article. J Neurosurg 113:1029\u20131035","journal-title":"J Neurosurg"},{"key":"2321_CR18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/jnnp.20.1.22","volume":"20","author":"D Simpson","year":"1957","unstructured":"Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22\u201339","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2321_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol (Berl) 114:97\u2013109. doi: 10.1007\/s00401-007-0243-4","journal-title":"Acta Neuropathol (Berl)"},{"key":"2321_CR20","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/neuonc\/nov247","volume":"18","author":"CL Rogers","year":"2016","unstructured":"Rogers CL, Perry A, Pugh S, Vogelbaum MA, Brachman D, McMillan W, Jenrette J, Barani I, Shrieve D, Sloan A, Bovi J, Kwok Y, Burri SH, Chao ST, Spalding AC, Anscher MS, Bloom B, Mehta M (2016) Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG trial 0539. Neurooncol 18:565\u2013574. doi: 10.1093\/neuonc\/nov247","journal-title":"Neurooncol"},{"key":"2321_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3171\/2014.7.jns131644","volume":"122","author":"L Rogers","year":"2015","unstructured":"Rogers L, Barani I, Chamberlain M, Kaley TJ, McDermott M, Raizer J, Schiff D, Weber DC, Wen PY, Vogelbaum MA (2015) Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg 122: 4\u201323. doi: 10.3171\/2014.7.jns131644","journal-title":"J Neurosurg"},{"key":"2321_CR22","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.3171\/2015.1.focus14757","volume":"38","author":"SQ Sun","year":"2015","unstructured":"Sun SQ, Hawasli AH, Huang J, Chicoine MR, Kim AH (2015) An evidence-based treatment algorithm for the management of WHO Grade II and III meningiomas. Neurosurg Focus 38:E3. doi: 10.3171\/2015.1.focus14757","journal-title":"Neurosurg Focus"},{"key":"2321_CR23","doi-asserted-by":"publisher","unstructured":"Nanda A, Bir SC, Maiti TK, Konar SK, Missios S, Guthikonda B (2016) Relevance of Simpson grading system and recurrence-free survival after surgery for World Health Organization Grade I meningioma. J Neurosurg 1\u201311. doi: 10.3171\/2016.1.jns151842","DOI":"10.3171\/2016.1.jns151842"},{"key":"2321_CR24","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11060-009-9948-7","volume":"96","author":"AD Norden","year":"2010","unstructured":"Norden AD, Raizer JJ, Abrey LE, Lamborn KR, Lassman AB, Chang SM, Yung WK, Gilbert MR, Fine HA, Mehta M, Deangelis LM, Cloughesy TF, Robins HI, Aldape K, Dancey J, Prados MD, Lieberman F, Wen PY (2010) Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma. J Neurooncol 96:211\u2013217. doi: 10.1007\/s11060-009-9948-7","journal-title":"J Neurooncol"},{"key":"2321_CR25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1212\/wnl.0000000000001153","volume":"84","author":"AD Norden","year":"2015","unstructured":"Norden AD, Ligon KL, Hammond SN, Muzikansky A, Reardon DA, Kaley TJ, Batchelor TT, Plotkin SR, Raizer JJ, Wong ET, Drappatz J, Lesser GJ, Haidar S, Beroukhim R, Lee EQ, Doherty L, Lafrankie D, Gaffey SC, Gerard M, Smith KH, McCluskey C, Phuphanich S, Wen PY (2015) Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma. Neurology 84:280\u2013286. doi: 10.1212\/wnl.0000000000001153","journal-title":"Neurology"},{"key":"2321_CR26","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s00280-014-2422-z","volume":"73","author":"M Simo","year":"2014","unstructured":"Simo M, Argyriou AA, Macia M, Plans G, Majos C, Vidal N, Gil M, Bruna J (2014) Recurrent high-grade meningioma: a phase II trial with somatostatin analogue therapy. Cancer Chemother Pharmacol 73:919\u2013923. doi: 10.1007\/s00280-014-2422-z","journal-title":"Cancer Chemother Pharmacol"},{"key":"2321_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s11060-011-0741-z","volume":"107","author":"MC Chamberlain","year":"2012","unstructured":"Chamberlain MC (2012) Hydroxyurea for recurrent surgery and radiation refractory high-grade meningioma. J Neurooncol 107:315\u2013321. doi: 10.1007\/s11060-011-0741-z","journal-title":"J Neurooncol"},{"key":"2321_CR28","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s11060-011-0541-5","volume":"104","author":"MC Chamberlain","year":"2011","unstructured":"Chamberlain MC, Johnston SK (2011) Hydroxyurea for recurrent surgery and radiation refractory meningioma: a retrospective case series. J Neurooncol 104:765\u2013771. doi: 10.1007\/s11060-011-0541-5","journal-title":"J Neurooncol"},{"key":"2321_CR29","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/neuonc\/nou148","volume":"17","author":"TJ Kaley","year":"2015","unstructured":"Kaley TJ, Wen P, Schiff D, Ligon K, Haidar S, Karimi S, Lassman AB, Nolan CP, DeAngelis LM, Gavrilovic I, Norden A, Drappatz J, Lee EQ, Purow B, Plotkin SR, Batchelor T, Abrey LE, Omuro A (2015) Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma. Neurooncol 17:116\u2013121. doi: 10.1093\/neuonc\/nou148","journal-title":"Neurooncol"},{"key":"2321_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11060-014-1358-9","volume":"117","author":"JJ Raizer","year":"2014","unstructured":"Raizer JJ, Grimm SA, Rademaker A, Chandler JP, Muro K, Helenowski I, Rice L, McCarthy K, Johnston SK, Mrugala MM, Chamberlain M (2014) A phase II trial of PTK787\/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas. J Neurooncol 117:93\u2013101. doi: 10.1007\/s11060-014-1358-9","journal-title":"J Neurooncol"},{"key":"2321_CR31","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11060-011-0687-1","volume":"106","author":"DA Reardon","year":"2012","unstructured":"Reardon DA, Norden AD, Desjardins A, Vredenburgh JJ, Herndon JE 2nd, Coan A, Sampson JH, Gururangan S, Peters KB, McLendon RE, Norfleet JA, Lipp ES, Drappatz J, Wen PY, Friedman HS (2012) Phase II study of Gleevec(R) plus hydroxyurea (HU) in adults with progressive or recurrent meningioma. J Neurooncol 106:409\u2013415. doi: 10.1007\/s11060-011-0687-1","journal-title":"J Neurooncol"},{"key":"2321_CR32","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1215\/15228517-2009-010","volume":"11","author":"PY Wen","year":"2009","unstructured":"Wen PY, Yung WK, Lamborn KR, Norden AD, Cloughesy TF, Abrey LE, Fine HA, Chang SM, Robins HI, Fink K, Deangelis LM, Mehta M, Di Tomaso E, Drappatz J, Kesari S, Ligon KL, Aldape K, Jain RK, Stiles CD, Egorin MJ, Prados MD (2009) Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01\u201308). Neurooncol 11:853\u2013860. doi: 10.1215\/15228517-2009-010","journal-title":"Neurooncol"},{"key":"2321_CR33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11060-012-0886-4","volume":"109","author":"L Nayak","year":"2012","unstructured":"Nayak L, Iwamoto FM, Rudnick JD, Norden AD, Lee EQ, Drappatz J, Omuro A, Kaley TJ (2012) Atypical and anaplastic meningiomas treated with bevacizumab. J Neurooncol 109:187\u2013193. doi: 10.1007\/s11060-012-0886-4","journal-title":"J Neurooncol"},{"key":"2321_CR34","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1212\/01.WNL.0000118300.82017.F4","volume":"62","author":"MC Chamberlain","year":"2004","unstructured":"Chamberlain MC, Tsao-Wei DD, Groshen S (2004) Temozolomide for treatment-resistant recurrent meningioma. Neurology 62:1210\u20131212","journal-title":"Neurology"},{"key":"2321_CR35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2217\/cns.13.17","volume":"2","author":"MC Chamberlain","year":"2013","unstructured":"Chamberlain MC (2013) IFN-alpha for recurrent surgery- and radiation-refractory high-grade meningioma: a retrospective case series. CNS Oncol 2:227\u2013235. doi: 10.2217\/cns.13.17","journal-title":"CNS Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-016-2321-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-016-2321-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-016-2321-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T23:54:27Z","timestamp":1498348467000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-016-2321-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,18]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["2321"],"URL":"https:\/\/doi.org\/10.1007\/s11060-016-2321-8","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,18]]}}}